Detalhe da pesquisa
1.
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.
N Engl J Med
; 389(24): 2233-2244, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38091530
2.
Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108.
Cancer
; 126(2): 432-443, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31581306
3.
Statistical and practical considerations in designing of immuno-oncology trials.
J Biopharm Stat
; 30(6): 1130-1146, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33706684
4.
Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi-center HGB-206 trial.
Am J Hematol
; 95(9): E239-E242, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32401372
5.
Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis.
Nat Commun
; 14(1): 3631, 2023 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37336877
6.
Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial.
Nat Med
; 28(5): 1042-1049, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35241844
7.
A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine.
Vaccine
; 39(20): 2791-2799, 2021 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33707061
8.
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis.
Nat Med
; 27(11): 2025-2031, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34526698